Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 34171-40-9 | MDL No. : | MFCD11040247 |
Formula : | C6H6Cl2N2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YFYFVWTWMBQHOH-UHFFFAOYSA-N |
M.W : | 177.03 | Pubchem ID : | 10012458 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 41.83 |
TPSA : | 25.78 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.31 cm/s |
Log Po/w (iLOGP) : | 2.19 |
Log Po/w (XLOGP3) : | 2.92 |
Log Po/w (WLOGP) : | 2.35 |
Log Po/w (MLOGP) : | 1.49 |
Log Po/w (SILICOS-IT) : | 2.92 |
Consensus Log Po/w : | 2.37 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.16 |
Solubility : | 0.124 mg/ml ; 0.0007 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.12 |
Solubility : | 0.133 mg/ml ; 0.000754 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.67 |
Solubility : | 0.0375 mg/ml ; 0.000212 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.84 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | at 120℃; for 5 h; | Step A: Synthesis of 2,4-dichloro-5-ethylpyrimidine. To a suspension of 5-ethyluracil (1 g, 7.1 mmol) in POCl3 (4.5 mL) was slowly added N,N-dimethylaniline (1 mL). The reaction was heated at reflux (~120 °C) for 5 h until the starting material was completely dissolved and the entire solution turned a purple color. The mixture was allowed to cool and poured very slowly into ice (~40 g). The resulting ppt was filtered and washed with ice water. The ppt was dissolved with a minimal amount of DCM and poured onto a short column of silica gel, and the product (1.2 g, ~ 100 percent) was obtained by column chromatography with DCM. 1H NMR (400 MHz, CDCl3) δ 8.42 (s, 1 H), 2.75 (q, 2 H, J = 7.6 Hz), 1.29 (t, 3 H, J = 7.6 Hz). |
85.2% | for 3.8 h; Heating / reflux | N, N-DIISOPROPYLETHYLAMINE (195 mL, 0.86 mol) (Aldrich) was added slowly to a mixture of 5-ethyl uracil (52.3 g, 0.37 mol) (from Example LC, suprn) and phosphorous oxychloride (150 mL, 1.61 mol) (Aldrich) with external cooling in a cold water bath. The mixture was heated at reflux for 3.8 hours and cooled to room temperature. Mixture was then poured into ice (300 g). Ethyl acetate (100 mL) was added and mixture stirred at 20 °C for 30 minutes with cooling in an ice-water bath. The resulting mixture was filtered through CELITEE and the filtrate extracted with ethyl acetate-hexanes (1: 1,3 X 300 mL). The combined organic layers was washed with water (250 mL), dried over sodium sulfate, filtered and concentrated to dryness. This residue was dissolved in ethyl acetate- hexanes (1 : 1) and filtered through TLC grade silica gel and eluting with the same solvent. The filtrate was concentrated to dryness to give 2,4-dichloro-5-ethyl-pyrimidine. (Yield 56.3 g, 85.2percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
~ 100% | With N,N-dimethyl-aniline; trichlorophosphate; at 120℃; for 5h; | Step A: Synthesis of 2,4-dichloro-5-ethylpyrimidine. To a suspension of 5-ethyluracil (1 g, 7.1 mmol) in POCl3 (4.5 mL) was slowly added N,N-dimethylaniline (1 mL). The reaction was heated at reflux (~120 C) for 5 h until the starting material was completely dissolved and the entire solution turned a purple color. The mixture was allowed to cool and poured very slowly into ice (~40 g). The resulting ppt was filtered and washed with ice water. The ppt was dissolved with a minimal amount of DCM and poured onto a short column of silica gel, and the product (1.2 g, ~ 100 %) was obtained by column chromatography with DCM. 1H NMR (400 MHz, CDCl3) delta 8.42 (s, 1 H), 2.75 (q, 2 H, J = 7.6 Hz), 1.29 (t, 3 H, J = 7.6 Hz). |
85.2% | With N-ethyl-N,N-diisopropylamine; trichlorophosphate; for 3.8h;Heating / reflux; | N, N-DIISOPROPYLETHYLAMINE (195 mL, 0.86 mol) (Aldrich) was added slowly to a mixture of 5-ethyl uracil (52.3 g, 0.37 mol) (from Example LC, suprn) and phosphorous oxychloride (150 mL, 1.61 mol) (Aldrich) with external cooling in a cold water bath. The mixture was heated at reflux for 3.8 hours and cooled to room temperature. Mixture was then poured into ice (300 g). Ethyl acetate (100 mL) was added and mixture stirred at 20 C for 30 minutes with cooling in an ice-water bath. The resulting mixture was filtered through CELITEE and the filtrate extracted with ethyl acetate-hexanes (1: 1,3 X 300 mL). The combined organic layers was washed with water (250 mL), dried over sodium sulfate, filtered and concentrated to dryness. This residue was dissolved in ethyl acetate- hexanes (1 : 1) and filtered through TLC grade silica gel and eluting with the same solvent. The filtrate was concentrated to dryness to give 2,4-dichloro-5-ethyl-pyrimidine. (Yield 56.3 g, 85.2%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
100% | With N-Bromosuccinimide; 2,2'-azobis(isobutyronitrile); In tetrachloromethane; for 1.5h;Heating / reflux; | N-Bromosuccimimide (64.2 g, 0.35 mol) (Aldrich) and 2, 2'-azo-bis- isobutyronitrile (AIBN, 1.78 g) (Aldrich) were added to a solution of 2, 4-dichloro-5- ethylpyrimidine (56.3 g, 0.32 mol) (from Example LC, supra) in carbon tetrachloride (400 mL). The mixture was heated at reflux for 1.5 hours and cooled to room temperature. Reaction mixture was filtered through TLC grade silica gel and eluted with ethyl acetate- hexanes (1: 8). The filtrate was concentrated to dryness to give ()-2, 4-DICHLORO-5-(1- bromoethyl) -pyrimidine. (Yield 81.3 g, 100%). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | In tetrahydrofuran; at 5 - 10℃; for 2h; | Step B: Synthesis of N-(cis-4-1[4-(dimethylamino)-5-ethylpyrimidin-2-yl]amino)cyclohexyl)-3,4-difluorobenzamide. A solution of <strong>[34171-40-9]2,4-dichloro-5-ethylpyrimidine</strong> (1.2 g, 6.8 mmol), in THF (15 mL) was cooled to 5 C in an ice bath, and 2M-dimethylamine (7 mL, 2 eq.) was slowly added. The reaction was stirred for 2 h at around 10 C, and the volatile solvent was removed. The residue was purified by column chromatography (hexane:DCM = 50:50 to 10:90) to give 0.89 g (70 %) of 2-chloro-4-dimethylamino-5-ethylpyrimidine: ESI MS m/e = 186 M + H+. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
50% | Preparation of 2-chloro-5-ethyl-4-(4-methoxybenzyloxy)pyrimidineIn a round bottom flask, (4-methoxyphenyl)methanol (859 mg) and lithium f-butoxide (453 mg) are stirred in THF (5.65 ml_) at 70 C for 15 minutes and then cooled to room temperature. In a separate flask, 2,4- dichloro-5-ethylpyrimidine (1.00 g) is dissolved in DMF (10 ml_) and this solution is than transferred dropwise (over 30 minutes) to the previous mixture at 0 C and then let warmed to room temperature. After 3 hours, the reaction proved to be completed by GC-MS with an isomers ratio of ~ 18 / 1. Reaction mixture diluted with ethyl acetate and washed twice with water, once with brine, dried over sodium sulfate, filtered and concentrated to afford the crude. The residue was purified by flash column chromatography (S1O2, 5%-30% ethyl acetate / heptane) to provide 2-chloro-5-ethyl-4-(4- methoxybenzyloxy)pyrimidine (787 mg, 50%) as a colorless oil (Isomers ratio after purification ~ 32 / 1 ). MS (M+1 ): 279.0. 1H NMR (400 MHz, CDCI3) delta ppm 1.16 (m, J=7.43, 7.43 Hz, 3 H), 2.52 (q, J=7.62 Hz, 2 H), 3.81 (s, 3 H), 5.37 (s, 2 H), 6.85 - 6.95 (m, 2 H), 7.34 - 7.43 (m, 2 H), 8.10 (s, 1 H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
[473] A solution of 2,4-dichloro-5-ethylpyridimidine (0.50 g, 2.8 mmol) in DCE (5.6 mL) was cooled to 0 C before aluminum chloride (0.41 g, 3.1 mmol) was added portionwise. This mixture was warmed to ii and stirred for 15 mm before adding 2,3-dihydro-[1 ,4]oxazino[2,3,4-hi]indole (B2) (0.45 g, 2.8 mmol). The reaction was stirred at 80 C for I h before adding another portion of 2,3-dihydro-[1 ,4]oxazino[2,3,4- hijindole (B2) (0.45 g, 2.8 mmol). The reaction mixture was stirred at 80 C for an additional 2 h before cooling to 0 C. MeOH (5 mL) and water (10 mL) were added, and the resulting mixture was stirred at rt for 30 mm. The reaction was further diluted with water (20 mL) and the layers were separated. The aqueous phase was extracted with DCM (4 x 30 mL) and the combined organic layers were dried over magnesium sulfate, filtered, and concentrated in vacuo. The resulting residue was purified by flash?IflA flflfll rinA flflf%?S _fl.J t? Ifl _Ui_. r :.:I:._ A coiumn GflFOFfldIO9Fdfl 011 SIIIGd yei 1.070 -4 £070 LIL)IkCIL.&1IVI) U) dilOFU 0-z-cnI0F0-D-eInyIpyFImIuIn--yl)-2,3-dihydro-[1 ,4]oxazino[2,3,4-hi]indole (Cl) as an off-white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With (1,1'-bis(diphenylphosphino)ferrocene)palladium(II) dichloride; sodium carbonate; In water; N,N-dimethyl-formamide; at 100℃; for 14h; | A solution of <strong>[34171-40-9]5-ethyl-2,4-dichloropyrimidine</strong> (160 mg, 0.90 mmol), pyrazolo[1 ,5-a]pyridin-3- ylboronic acid pinacol ester (287 mg, 1.17 mmol), and [1 ,1 '-bis(diphenyl- phosphino)ferrocene]dichloropalladium(ll) (40 mg, 0.054 mmol) in DMF (9.0 mL) was added, followed by aqueous sodium carbonate (2.0 mL, 4.0 mmol). The mixture was then heated to 100 C and stirred for 14 h. Upon cooling, the mixture was concentrated in vacuo, and the resulting residue was diluted with 20% (v/v) MeOH in EtOAc (5 mL) and filtered through a Celite pad with additional 20% (v/v) MeOH in EtOAc (20 mL). The filtrate was then concentrated in vacuo and the resulting residue was purified by flash column chromatography on silica gel (0%? 5% MeOH/DCM) to afford 3-(2-chloro-5-ethylpyrimidin-4-yl)pyrazolo[1 ,5-a]pyridine (F1) as a white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
23%; 9% | In methanol; water; at 45℃; for 16h; | General procedure: Procedure A: A mixture of substituted 2,4-dichloropyrimidine (1.0 equiv.) and substituted aniline (1.15 equiv.) in MeOH/water (1 : 1.5, 0.2 M) was stirred at 45 C. The reaction time is indicated below. Upon cooling to ambient temperature, the desired product precipitated and was filtered, washed with MeOH/water (1 : 1.5, 20 mL), and dried. |
23%; 9% | In methanol; water; at 45℃; for 384h; | This was prepared from MA1-012 (0.531 g) and 3-methoxy-4-chloroaniline (0.473 g) using procedure A (reaction time, 16 h) to give the title compound as a white solid (0.202 g, 23%). Mp: 143-144 C. lH NMR (400 MHz, DMSO-ifc): delta 8.93 (s, IH, disappeared on D20 shake), 8.07 (s, IH), 7.53 (d, / = 2.3 Hz, IH), 7.37 (d, / = 8.6 Hz, IH), 7.31 (dd, / = 8.6, 2.3 Hz, IH), 3.83 (s, 3H), 2.61 (q, J = 7.4 Hz, 2H), 1.17 (t, / = 7.4 Hz, 3H). HPLC-MS (ESI+): m/z 300.1 [70%, (M37C135C1+H)+], m/z 298.1 [100%, (M35C135C1+H)+]. Further elution gave the bis- adddition side product MA1-025B (109 mg, 9%) as a yellow solid, Mp: 201 C (dec). HPLC: 99% [tR = 8.1 min, 65% MeOH, 35% water (with 0.1% TFA), 20 min]. lH NMR (400 MHz, DMSO-ifc): delta 9.20 (s, IH, disappeared on D20 shake), 8.48 (s, IH, 40% reduced on D20 shake), 7.97 (s, IH), 7.56 (d, / = 2.3 Hz, IH), 7.43 (d, / = 2.3 Hz, IH), 7.38 (dd, / = 8.6, 2.3 Hz, IH), 7.32 (d, / = 8.7 Hz, IH) 7.29 (dd, / = 8.6, 2.3 Hz, IH), 7.15 (d, / = 8.7 Hz, IH), 3.74 (s, 3H), 3.60 (s, 3H), 2.57 (q, / = 7.4 Hz, 2H), 1.18 (t, / = 7.4 Hz, 3H). HPLC-MS (ESI+): m/z 421.1 [70%, (M37C135C1+H)+], 419.2 [100%, (M35C135C1+H)+]. LC-MS (ESI+): 421.1 [70%, (M37C135C1+H)+], 419.1 [100%, (M35C135C1+H)+]. HRMS (ESI+): m/z calcd for C20H20CI2N4O2 (M+H)+ 1035.Pr ocedure A: A mixture of substituted 2,4-dichloropyrimidine (1.0 equiv.) and substituted aniline (1.15 equiv.) in MeOH/water (1 : 1.5, 0.2 M) was stirred at 45 C. The reaction time is indicated below. Upon cooling to ambient temperature, the desired product precipitated and was filtered, washed with MeOH/water (1 : 1.5, 20 mL), and dried. 2,5-Dichloro-/Y4-(4-[/Y-(l,l-dimethylethyl)sulfamoyl]phenyl)pyrimidin-4-amine (SG1-182): This was prepared from 2,4,5-trichloropyrimidine (0.500 g) and SG1-177 (0.715 g) using procedure A (stirred for 4 d). The crude solid was purified via flash chromatography (S1O2) eluting with hexanes/EtOAc (0: 10 to 4:6 v/v) to provide the title compound as a tangerine-colored solid (0.590 g, 58%). Mp: 180-181 C. NMR (400 MHz, DMSO-ifc): delta 9.73 (s, IH, disappeared on D20 shake), 8.46 (s, IH), 7.80 (s, 4H), 7.48 (s, IH, disappeared on D20 shake), 1.09 (s, 9H). HPLC-MS (ESI+): m/z 773.1 [10%, (MCl35Cl37+M35Cl35Cl+Na)+], 379.1 [10%, (MC137C137+H)+], 377.1 [70%, (MC135C137+H)+], 375.1 [100%, (M35C135C1+H)+]. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium phosphate; palladium bis[bis(diphenylphosphino)ferrocene] dichloride; In tetrahydrofuran; water; at 100℃; for 4h;Micellar solution; | 1-(phenylsulfonyl)-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile (1.8 g, 4.40 mmol, 1.0 eq), <strong>[34171-40-9]2,4-dichloro-5-ethylpyrimidine</strong> (778.60 mg, 4.40 mmol, 1.0 eq), K3PO4 (1.87 g, 8.80 mmol, 2 eq) and Pd(dppf)Cl2 (321.81 mg, 439.81 umol, 0.10 eq) in H2O (0.5 mL) and THF (5 mL) was degassed and then heated to 100C for 4 hrs under N2. TLC (Petroleum ether: EtOAc = 3:1, Rf = 0.24) shows a new spot. The mixture was cooled to 25C and concentrated in reduced pressure at 50C. H2O (20 mL) was added to the mixture. The aqueous phase was extracted with EtOAc (20 mL x 3). The combined organic phase was washed with brine (30 mL), dried with anhydrous Na2SO4, filtered and concentrated in vacuum. The residue was purified by silica gel chromatography: (Petroleum ether: EtOAc= 20:1~1:1) to afford 3-(2-chloro-5-ethylpyrimidin-4-yl)-1-(phenylsulfonyl)-1H-pyrrolo[2,3-b]pyridine-6-carbonitrile (1.1 g, crude) as yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Two reactions were carried out in parallel. To a mixture of <strong>[34171-40-9]2,4-dichloro-5-ethylpyrimidine</strong> (1.00 g, 5.65 mmol, 1.00 eq) in 1,2-dichloroethane (8.0 mL) was added AlCl3 (791 mg, 5.93 mmol, 324 uL, 1.05 eq) by portions at 10C under N2. The mixture was stirred at 80C for 1.5 hrs. Then 7-(methylsulfonyl)-1H-indole (805 mg, 4.12 mmol, 0.73 eq) in 1,2-dichloroethane (8.0 mL) was added drop-wise at 80C. The reaction mixture was stirred for 15 hrs at 80C. TLC showed 7-(methylsulfonyl)-1H-indole (Petroleum ether:EtOAc = 1:1, Rf = 0.51) remained and a new major spot (Petroleum ether: EtOAc = 1/1, Rf = 0.61) was detected. The two reactions were combined to work up. The mixture was purified by silica gel chromatography (100-200 mesh silica gel, Petroleum ether:EtOAc = 10:1,1:1) to afford 3-(2-chloro-5-ethylpyrimidin-4-yl)-7-(methylsulfonyl)-1H-indole (600 mg, 14% yield, 92% purity) as a yellow solid |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
34% | With tetrakis(triphenylphosphine) palladium(0); hexamethyldistannane; In toluene; at 100℃; for 12h;Inert atmosphere; | A mixture of 3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole-6-carbonitrile (1.00 g, 2.83 mmol, 1.00 eq), <strong>[34171-40-9]2,4-dichloro-5-ethylpyrimidine</strong> (602 mg, 3.40 mmol, 1.2 eq), trimethyl(trimethylstannyl)stannane (928 mg, 2.83 mmol, 587 uL, 1.00 eq), Pd(PPh3)4 (491 mg, 425 umol, 0.15 eq) in toluene (10 mL) was degassed and purged with Ar for 3 times, and then the mixture was stirred at 100C for 12 hrs under Ar atmosphere. TLC (Petroleum ether: EtOAc = 3: 1, Rf = 0.43) indicated one major new spot with larger polarity was detected. The reaction mixture was filtered and concentrated under reduced pressure to give a residue. The residue was purified by column chromatography (SiO2, Petroleum ether: EtOAc = 3: 1). 3-(2-chloro-5-ethylpyrimidin-4-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-indazole-6-carbonitrile (0.5 g, 34% yield) was obtained as a yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
36% | With tetrakis(triphenylphosphine) palladium(0); hexamethyldistannane; In toluene; at 100℃; for 12h;Inert atmosphere; | A mixture of 3-iodo-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-b]pyridine-6-carbonitrile (1.93 g, 5.45 mmol, 1 eq), <strong>[34171-40-9]2,4-dichloro-5-ethylpyrimidine</strong> (1.16 g, 6.54 mmol, 1.2 eq), 1,1,1,2,2,2-hexamethyldistannane (1.79 g, 5.45 mmol, 1 eq), Pd(PPh3)4 (630 mg, 545 umol, 0.1 eq) in toluene (20 mL) was degassed and purged with N2 for 3 times, and then the mixture was stirred at 100oC for 12 hrs under N2 atmosphere. LCMS showed desired MS was detected. The reaction mixture was concentrated under reduced pressure to remove toluene. The residue was purified by column chromatography (SiO2, Petroleum ether:EtOAc= 100:1 to 1:1) to give 3-(2-chloro-5-ethylpyrimidin-4-yl)-1-(tetrahydro-2H-pyran-2-yl)-1H-pyrazolo[3,4-b]pyridine-6-carbonitrile (730 mg, 1.98 mmol, 36% yield) as a yellow solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With palladium bis[bis(diphenylphosphino)ferrocene] dichloride; potassium carbonate; In 1,2-dimethoxyethane; water; at 20 - 80℃; for 2h;Inert atmosphere; | To a mixture of 2-[[7-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indazol-1-yl]methoxy]ethyltrimethylsilane (2 g, 3.57 mmol) and <strong>[34171-40-9]2,4-dichloro-5-ethylpyrimidine</strong> (947.53 mg, 5.36 mmol) in DME (25 mL) and H2O (5 mL) was added Pd(dppf)Cl2 (261.09 mg, 357.00 umol) and K2CO3 (986.33 mg, 7.14 mmol) in one portion at 20 C under N2. The mixture was stirred at 80 C for 2 h. The mixture was poured into water (100 mL) and extracted with EA (50 mL*2). The combined organic phase was washed with brine (100 mL*2), dried with anhydrous Na2SO4, filtered and concentrated in vacuum. The residue was purified by silica gel chromatography (PE/EA=100/1,40/1) to give 2-[[3-(2-chloro-5-ethylpyrimidin-4-yl)-7-fluoroindazol-1-yl]methoxy]ethyltrimethylsilane (600 mg, crude) as colorless oil. LCMS: M+H+: 407.1 1.087 min (5-95% ACN in H2O, 1.5 min). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
51.19% | With palladium bis[bis(diphenylphosphino)ferrocene] dichloride; sodium carbonate; In 1,4-dioxane; at 100℃; for 1h;Inert atmosphere; | To a mixture of 5-fluoro-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-tosyl-1H-pyrrolo[2,3-b]pyridine (850 mg, 2.04 mmol, 1.00 eq) and <strong>[34171-40-9]2,4-dichloro-5-ethylpyrimidine</strong> (361 mg, 2.04 mmol, 1.00 eq) in dioxane (15 mL) and H2O (2 mL) was added Pd(dppf)Cl2 (149 mg, 204 umol, 0.10 eq) and Na2CO3 (432 mg, 4.08 mmol, 2.00 eq) in one portion at 25C under N2. The mixture was stirred at 100C for 1 h. TLC (Petroleum ether: EtOAc = 1:1, Rf = 0.64) showed the reaction was completed. The mixture was cooled to 25C and concentrated in reduced pressure at 45C. The residue was poured into water (10 mL) and stirred for 1 min. The aqueous phase was extracted with EtOAc (5 mLx3). The combined organic phase was washed with brine (5 mLx1), dried with anhydrous Na2SO4, filtered and concentrated in vacuum. The residue was purified by silica gel chromatography (Petroleum ether: ethyl acetate = 10:1,1:1), to afford 3-(2-chloro-5-ethylpyrimidin-4-yl)-5-fluoro-1-tosyl-1H-pyrrolo[2,3-b]pyridine (450 mg, 1.04 mmol, 51.19% yield) as white solid. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With tetrakis(triphenylphosphine) palladium(0); lithium chloride; In toluene; at 100℃; for 5h;Inert atmosphere; | Compound 36. A mixture of compound 34 (100 mg, 234 mumol, 1 eq.), compound 35 (62 mg, 352 mumol, 1.5 eq.), Pd(PPh3)4 (27 mg, 23 mumol, 0.1 eq.), and LiCl (20 mg, 469 mumol, 2 eq.) in toluene (1 mL) was degassed and purged with N2 for 3 times. Then the mixture was stirred at 100 C for 5 h under N2. The reaction mixture was cooled down to 25 C and poured into sat. KF (10 mL) and stirred for 20 min. Then the mixture was extracted with EtOAc (10 mL x 2). The combined organics were washed with brine (20 mL), dried over Na2SO4, and concentrated in vacuo to afford crude compound 36 (40 mg) as a yellow solid, which was used directly in the next step without further purification. |
Tags: 34171-40-9 synthesis path| 34171-40-9 SDS| 34171-40-9 COA| 34171-40-9 purity| 34171-40-9 application| 34171-40-9 NMR| 34171-40-9 COA| 34171-40-9 structure
[ 1127-85-1 ]
2,4-Dichloro-5,6,7,8-tetrahydroquinazoline
Similarity: 0.91
[ 1780-38-7 ]
2,4,6-Trichloro-5-ethylpyrimidine
Similarity: 0.82
[ 1015846-32-8 ]
4-Chloro-5-isopropylpyrimidine
Similarity: 0.80
[ 1780-42-3 ]
2,4,6-Trichloro-5-isopropylpyrimidine
Similarity: 0.78
[ 1780-38-7 ]
2,4,6-Trichloro-5-ethylpyrimidine
Similarity: 0.82
[ 1015846-32-8 ]
4-Chloro-5-isopropylpyrimidine
Similarity: 0.80
[ 1780-42-3 ]
2,4,6-Trichloro-5-isopropylpyrimidine
Similarity: 0.78
[ 1780-36-5 ]
2,4,6-Trichloro-5-methylpyrimidine
Similarity: 0.75
Precautionary Statements-General | |
Code | Phrase |
P101 | If medical advice is needed,have product container or label at hand. |
P102 | Keep out of reach of children. |
P103 | Read label before use |
Prevention | |
Code | Phrase |
P201 | Obtain special instructions before use. |
P202 | Do not handle until all safety precautions have been read and understood. |
P210 | Keep away from heat/sparks/open flames/hot surfaces. - No smoking. |
P211 | Do not spray on an open flame or other ignition source. |
P220 | Keep/Store away from clothing/combustible materials. |
P221 | Take any precaution to avoid mixing with combustibles |
P222 | Do not allow contact with air. |
P223 | Keep away from any possible contact with water, because of violent reaction and possible flash fire. |
P230 | Keep wetted |
P231 | Handle under inert gas. |
P232 | Protect from moisture. |
P233 | Keep container tightly closed. |
P234 | Keep only in original container. |
P235 | Keep cool |
P240 | Ground/bond container and receiving equipment. |
P241 | Use explosion-proof electrical/ventilating/lighting/equipment. |
P242 | Use only non-sparking tools. |
P243 | Take precautionary measures against static discharge. |
P244 | Keep reduction valves free from grease and oil. |
P250 | Do not subject to grinding/shock/friction. |
P251 | Pressurized container: Do not pierce or burn, even after use. |
P260 | Do not breathe dust/fume/gas/mist/vapours/spray. |
P261 | Avoid breathing dust/fume/gas/mist/vapours/spray. |
P262 | Do not get in eyes, on skin, or on clothing. |
P263 | Avoid contact during pregnancy/while nursing. |
P264 | Wash hands thoroughly after handling. |
P265 | Wash skin thouroughly after handling. |
P270 | Do not eat, drink or smoke when using this product. |
P271 | Use only outdoors or in a well-ventilated area. |
P272 | Contaminated work clothing should not be allowed out of the workplace. |
P273 | Avoid release to the environment. |
P280 | Wear protective gloves/protective clothing/eye protection/face protection. |
P281 | Use personal protective equipment as required. |
P282 | Wear cold insulating gloves/face shield/eye protection. |
P283 | Wear fire/flame resistant/retardant clothing. |
P284 | Wear respiratory protection. |
P285 | In case of inadequate ventilation wear respiratory protection. |
P231 + P232 | Handle under inert gas. Protect from moisture. |
P235 + P410 | Keep cool. Protect from sunlight. |
Response | |
Code | Phrase |
P301 | IF SWALLOWED: |
P304 | IF INHALED: |
P305 | IF IN EYES: |
P306 | IF ON CLOTHING: |
P307 | IF exposed: |
P308 | IF exposed or concerned: |
P309 | IF exposed or if you feel unwell: |
P310 | Immediately call a POISON CENTER or doctor/physician. |
P311 | Call a POISON CENTER or doctor/physician. |
P312 | Call a POISON CENTER or doctor/physician if you feel unwell. |
P313 | Get medical advice/attention. |
P314 | Get medical advice/attention if you feel unwell. |
P315 | Get immediate medical advice/attention. |
P320 | |
P302 + P352 | IF ON SKIN: wash with plenty of soap and water. |
P321 | |
P322 | |
P330 | Rinse mouth. |
P331 | Do NOT induce vomiting. |
P332 | IF SKIN irritation occurs: |
P333 | If skin irritation or rash occurs: |
P334 | Immerse in cool water/wrap n wet bandages. |
P335 | Brush off loose particles from skin. |
P336 | Thaw frosted parts with lukewarm water. Do not rub affected area. |
P337 | If eye irritation persists: |
P338 | Remove contact lenses, if present and easy to do. Continue rinsing. |
P340 | Remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P341 | If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P342 | If experiencing respiratory symptoms: |
P350 | Gently wash with plenty of soap and water. |
P351 | Rinse cautiously with water for several minutes. |
P352 | Wash with plenty of soap and water. |
P353 | Rinse skin with water/shower. |
P360 | Rinse immediately contaminated clothing and skin with plenty of water before removing clothes. |
P361 | Remove/Take off immediately all contaminated clothing. |
P362 | Take off contaminated clothing and wash before reuse. |
P363 | Wash contaminated clothing before reuse. |
P370 | In case of fire: |
P371 | In case of major fire and large quantities: |
P372 | Explosion risk in case of fire. |
P373 | DO NOT fight fire when fire reaches explosives. |
P374 | Fight fire with normal precautions from a reasonable distance. |
P376 | Stop leak if safe to do so. Oxidising gases (section 2.4) 1 |
P377 | Leaking gas fire: Do not extinguish, unless leak can be stopped safely. |
P378 | |
P380 | Evacuate area. |
P381 | Eliminate all ignition sources if safe to do so. |
P390 | Absorb spillage to prevent material damage. |
P391 | Collect spillage. Hazardous to the aquatic environment |
P301 + P310 | IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. |
P301 + P312 | IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell. |
P301 + P330 + P331 | IF SWALLOWED: Rinse mouth. Do NOT induce vomiting. |
P302 + P334 | IF ON SKIN: Immerse in cool water/wrap in wet bandages. |
P302 + P350 | IF ON SKIN: Gently wash with plenty of soap and water. |
P303 + P361 + P353 | IF ON SKIN (or hair): Remove/Take off Immediately all contaminated clothing. Rinse SKIN with water/shower. |
P304 + P312 | IF INHALED: Call a POISON CENTER or doctor/physician if you feel unwell. |
P304 + P340 | IF INHALED: Remove victim to fresh air and Keep at rest in a position comfortable for breathing. |
P304 + P341 | IF INHALED: If breathing is difficult, remove victim to fresh air and keep at rest in a position comfortable for breathing. |
P305 + P351 + P338 | IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. |
P306 + P360 | IF ON CLOTHING: Rinse Immediately contaminated CLOTHING and SKIN with plenty of water before removing clothes. |
P307 + P311 | IF exposed: call a POISON CENTER or doctor/physician. |
P308 + P313 | IF exposed or concerned: Get medical advice/attention. |
P309 + P311 | IF exposed or if you feel unwell: call a POISON CENTER or doctor/physician. |
P332 + P313 | IF SKIN irritation occurs: Get medical advice/attention. |
P333 + P313 | IF SKIN irritation or rash occurs: Get medical advice/attention. |
P335 + P334 | Brush off loose particles from skin. Immerse in cool water/wrap in wet bandages. |
P337 + P313 | IF eye irritation persists: Get medical advice/attention. |
P342 + P311 | IF experiencing respiratory symptoms: call a POISON CENTER or doctor/physician. |
P370 + P376 | In case of fire: Stop leak if safe to Do so. |
P370 + P378 | In case of fire: |
P370 + P380 | In case of fire: Evacuate area. |
P370 + P380 + P375 | In case of fire: Evacuate area. Fight fire remotely due to the risk of explosion. |
P371 + P380 + P375 | In case of major fire and large quantities: Evacuate area. Fight fire remotely due to the risk of explosion. |
Storage | |
Code | Phrase |
P401 | |
P402 | Store in a dry place. |
P403 | Store in a well-ventilated place. |
P404 | Store in a closed container. |
P405 | Store locked up. |
P406 | Store in corrosive resistant/ container with a resistant inner liner. |
P407 | Maintain air gap between stacks/pallets. |
P410 | Protect from sunlight. |
P411 | |
P412 | Do not expose to temperatures exceeding 50 oC/ 122 oF. |
P413 | |
P420 | Store away from other materials. |
P422 | |
P402 + P404 | Store in a dry place. Store in a closed container. |
P403 + P233 | Store in a well-ventilated place. Keep container tightly closed. |
P403 + P235 | Store in a well-ventilated place. Keep cool. |
P410 + P403 | Protect from sunlight. Store in a well-ventilated place. |
P410 + P412 | Protect from sunlight. Do not expose to temperatures exceeding 50 oC/122oF. |
P411 + P235 | Keep cool. |
Disposal | |
Code | Phrase |
P501 | Dispose of contents/container to ... |
P502 | Refer to manufacturer/supplier for information on recovery/recycling |
Physical hazards | |
Code | Phrase |
H200 | Unstable explosive |
H201 | Explosive; mass explosion hazard |
H202 | Explosive; severe projection hazard |
H203 | Explosive; fire, blast or projection hazard |
H204 | Fire or projection hazard |
H205 | May mass explode in fire |
H220 | Extremely flammable gas |
H221 | Flammable gas |
H222 | Extremely flammable aerosol |
H223 | Flammable aerosol |
H224 | Extremely flammable liquid and vapour |
H225 | Highly flammable liquid and vapour |
H226 | Flammable liquid and vapour |
H227 | Combustible liquid |
H228 | Flammable solid |
H229 | Pressurized container: may burst if heated |
H230 | May react explosively even in the absence of air |
H231 | May react explosively even in the absence of air at elevated pressure and/or temperature |
H240 | Heating may cause an explosion |
H241 | Heating may cause a fire or explosion |
H242 | Heating may cause a fire |
H250 | Catches fire spontaneously if exposed to air |
H251 | Self-heating; may catch fire |
H252 | Self-heating in large quantities; may catch fire |
H260 | In contact with water releases flammable gases which may ignite spontaneously |
H261 | In contact with water releases flammable gas |
H270 | May cause or intensify fire; oxidizer |
H271 | May cause fire or explosion; strong oxidizer |
H272 | May intensify fire; oxidizer |
H280 | Contains gas under pressure; may explode if heated |
H281 | Contains refrigerated gas; may cause cryogenic burns or injury |
H290 | May be corrosive to metals |
Health hazards | |
Code | Phrase |
H300 | Fatal if swallowed |
H301 | Toxic if swallowed |
H302 | Harmful if swallowed |
H303 | May be harmful if swallowed |
H304 | May be fatal if swallowed and enters airways |
H305 | May be harmful if swallowed and enters airways |
H310 | Fatal in contact with skin |
H311 | Toxic in contact with skin |
H312 | Harmful in contact with skin |
H313 | May be harmful in contact with skin |
H314 | Causes severe skin burns and eye damage |
H315 | Causes skin irritation |
H316 | Causes mild skin irritation |
H317 | May cause an allergic skin reaction |
H318 | Causes serious eye damage |
H319 | Causes serious eye irritation |
H320 | Causes eye irritation |
H330 | Fatal if inhaled |
H331 | Toxic if inhaled |
H332 | Harmful if inhaled |
H333 | May be harmful if inhaled |
H334 | May cause allergy or asthma symptoms or breathing difficulties if inhaled |
H335 | May cause respiratory irritation |
H336 | May cause drowsiness or dizziness |
H340 | May cause genetic defects |
H341 | Suspected of causing genetic defects |
H350 | May cause cancer |
H351 | Suspected of causing cancer |
H360 | May damage fertility or the unborn child |
H361 | Suspected of damaging fertility or the unborn child |
H361d | Suspected of damaging the unborn child |
H362 | May cause harm to breast-fed children |
H370 | Causes damage to organs |
H371 | May cause damage to organs |
H372 | Causes damage to organs through prolonged or repeated exposure |
H373 | May cause damage to organs through prolonged or repeated exposure |
Environmental hazards | |
Code | Phrase |
H400 | Very toxic to aquatic life |
H401 | Toxic to aquatic life |
H402 | Harmful to aquatic life |
H410 | Very toxic to aquatic life with long-lasting effects |
H411 | Toxic to aquatic life with long-lasting effects |
H412 | Harmful to aquatic life with long-lasting effects |
H413 | May cause long-lasting harmful effects to aquatic life |
H420 | Harms public health and the environment by destroying ozone in the upper atmosphere |
Sorry,this product has been discontinued.
Home
* Country/Region
* Quantity Required :
* Cat. No.:
* CAS No :
* Product Name :
* Additional Information :